1. Brainware University Digital Repository
  2. Serial Abstracting Service
  3. Journal & Magazine Article Abstracts
  4. Indian Journal of Pharmacology
  5. Vol 58, No. 3, 2026
Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/4939
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBikash Ranjan Meher-
dc.date.accessioned2026-05-29T12:22:41Z-
dc.date.available2026-05-29T12:22:41Z-
dc.date.issued2026-05-29-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/4939-
dc.descriptionVol 58, No. 3, p 189en_US
dc.language.isoenen_US
dc.subjectEffectivenessen_US
dc.subjectgeneralizabilityen_US
dc.subjectpost-marketing safety surveillanceen_US
dc.subjectreal-world studyen_US
dc.titleAfter the greeb light : evaluating drugs in phase IV studiessen_US
dc.typeOtheren_US
Appears in Collections:Vol 58, No. 3, 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol 58, No. 3, p 18977.29 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.